Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Bronchiectasis, Decreased nasal nitric oxide, and Pneumonia; and very common findings: Recurrent sinusitis. 9 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 4 | Bronchiectasis, Chronic pulmonary obstruction, Difficulty breathing (respiratory insufficiency) |
MCIDAS encodes multiciliate differentiation and DNA synthesis associated cell cycle protein (385 aa). Transcription regulator specifically required for multiciliate cell differentiation. Highest expression in Thyroid (1.8 TPM) and Stomach (1.7 TPM).
Ciliary dyskinesia, primary, 42 is caused by mutations in the MCIDAS gene on chromosome 5.
MCIDAS is classified as a druggable target with score 0.0.
Genetic testing for MCIDAS is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for ciliary dyskinesia, primary, 42 has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 1 very common feature.
No clinical trials have been registered for ciliary dyskinesia, primary, 42.
21 publications have been identified in PubMed for ciliary dyskinesia, primary, 42. Research spans Case Report / Case Series (33%), Epidemiology / Natural History (33%), and Diagnostic / Biomarker (24%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 33% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about ciliary dyskinesia, primary, 42
Disease patterns and progression
7 |
33% |
Testing and diagnosis research | 5 | 24% |
Research summaries | 2 | 10% |
Nussstein H (2026). [PMID: 40967762](https://pubmed.ncbi.nlm.nih.gov/40967762/). *Eur Respir J*. [Epidemiology / Natural History]
McCoy J (2026). [PMID: 42001405](https://pubmed.ncbi.nlm.nih.gov/42001405/). *Pediatr Pulmonol*. [Diagnostic / Biomarker]
Schreck LD (2026). [PMID: 41561100](https://pubmed.ncbi.nlm.nih.gov/41561100/). *ERJ Open Res*. [Epidemiology / Natural History]
Bilgiç I (2026). [PMID: 41981340](https://pubmed.ncbi.nlm.nih.gov/41981340/). *Eur J Pediatr*. [Diagnostic / Biomarker]
Gupta P (2025). [PMID: 40213258](https://pubmed.ncbi.nlm.nih.gov/40213258/). *Ann Med Surg (Lond)*. [Case Report / Case Series]
Chang J (2025). [PMID: 40763972](https://pubmed.ncbi.nlm.nih.gov/40763972/). *Zhonghua Yi Xue Yi Chuan Xue Za Zhi*. [Case Report / Case Series]
Karabiber E (2025). [PMID: 39433023](https://pubmed.ncbi.nlm.nih.gov/39433023/). *Int Arch Allergy Immunol*. [Epidemiology / Natural History]
Liu J (2025). [PMID: 40257705](https://pubmed.ncbi.nlm.nih.gov/40257705/). *J Assist Reprod Genet*. [Review / Meta-Analysis]
Hijikata M (2025). [PMID: 39462806](https://pubmed.ncbi.nlm.nih.gov/39462806/). *Clin Genet*. [Diagnostic / Biomarker]
Amirav I (2025). [PMID: 40694277](https://pubmed.ncbi.nlm.nih.gov/40694277/). *Adv Ther*. [Case Report / Case Series]